Literature DB >> 18479837

Unaltered hormonal response to stress in a mouse model of fragile X syndrome.

Mei Qin1, Carolyn Beebe Smith.   

Abstract

Reports in the clinical literature and studies of fmr1 knockout mice have led to the hypothesis that, in addition to mental retardation, fragile X syndrome is characterized by a dysregulation of hypothalamic-pituitary-adrenal axis function. We have systematically examined this hypothesis by studying the effects of stress on adrenocorticotrophic hormone and corticosterone levels in adult, male fmr1 knockout mice. Initially we determined the circadian rhythms of the plasma hormone levels in both wild-type and fmr1 knockout mice and established the optimal time to impose the stress. We found no genotypic differences in the circadian rhythms of either hormone. We studied two types of stressors, immobilization and spatial novelty; spatial novelty was 5min in an elevated plus-maze. We varied the duration of immobilization and followed the time course of recovery of hormones to their pre-stress levels. Despite the lower anxiety exhibited by fmr1 knockout mice in the elevated plus-maze, hormonal responses to and recovery from this spatial novelty were similar in both genotypes. Further, we found no genotypic differences in hormonal responses to immobilization stress. The results of our study indicate that, in FVB/NJ mice, the hormonal response to and recovery from acute stress is unaltered by the lack of fragile X mental retardation protein.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18479837      PMCID: PMC2615669          DOI: 10.1016/j.psyneuen.2008.03.010

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  20 in total

1.  Increased social fear and decreased fear of objects in monkeys with neonatal amygdala lesions.

Authors:  M D Prather; P Lavenex; M L Mauldin-Jourdain; W A Mason; J P Capitanio; S P Mendoza; D G Amaral
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

2.  Electrodermal responses to sensory stimuli in individuals with fragile X syndrome: a preliminary report.

Authors:  L J Miller; D N McIntosh; J McGrath; V Shyu; M Lampe; A K Taylor; F Tassone; K Neitzel; T Stackhouse; R J Hagerman
Journal:  Am J Med Genet       Date:  1999-04-02

3.  Cortisol and social stressors in children with fragile X: a pilot study.

Authors:  J M Wisbeck; L C Huffman; L Freund; M R Gunnar; E P Davis; A L Reiss
Journal:  J Dev Behav Pediatr       Date:  2000-08       Impact factor: 2.225

4.  Increased rates of cerebral glucose metabolism in a mouse model of fragile X mental retardation.

Authors:  Mei Qin; Julia Kang; Carolyn Beebe Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-11       Impact factor: 11.205

5.  Fmr1 knockout mouse has a distinctive strain-specific learning impairment.

Authors:  C Dobkin; A Rabe; R Dumas; A El Idrissi; H Haubenstock; W T Brown
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

Review 6.  Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies.

Authors:  J N Crawley; J K Belknap; A Collins; J C Crabbe; W Frankel; N Henderson; R J Hitzemann; S C Maxson; L L Miner; A J Silva; J M Wehner; A Wynshaw-Boris; R Paylor
Journal:  Psychopharmacology (Berl)       Date:  1997-07       Impact factor: 4.530

7.  Fmr1 knockout mice: a model to study fragile X mental retardation. The Dutch-Belgian Fragile X Consortium.

Authors: 
Journal:  Cell       Date:  1994-07-15       Impact factor: 41.582

8.  Anxiety, fears, and phobias in persons with Williams syndrome.

Authors:  Elisabeth M Dykens
Journal:  Dev Neuropsychol       Date:  2003       Impact factor: 2.253

9.  RNA cargoes associating with FMRP reveal deficits in cellular functioning in Fmr1 null mice.

Authors:  Kevin Y Miyashiro; Andrea Beckel-Mitchener; T Patrick Purk; Kevin G Becker; Tanya Barret; Lei Liu; Salvatore Carbonetto; Ivan Jeanne Weiler; William T Greenough; James Eberwine
Journal:  Neuron       Date:  2003-02-06       Impact factor: 17.173

10.  Cortisol and behavior in fragile X syndrome.

Authors:  D Hessl; B Glaser; J Dyer-Friedman; C Blasey; T Hastie; M Gunnar; A L Reiss
Journal:  Psychoneuroendocrinology       Date:  2002-10       Impact factor: 4.905

View more
  10 in total

1.  Genetic manipulation of STEP reverses behavioral abnormalities in a fragile X syndrome mouse model.

Authors:  S M Goebel-Goody; E D Wilson-Wallis; S Royston; S M Tagliatela; J R Naegele; P J Lombroso
Journal:  Genes Brain Behav       Date:  2012-04-06       Impact factor: 3.449

2.  Effects of chronic immobilization stress on anxiety-like behavior and basolateral amygdala morphology in Fmr1 knockout mice.

Authors:  M Qin; Z Xia; T Huang; C B Smith
Journal:  Neuroscience       Date:  2011-06-22       Impact factor: 3.590

3.  Cholesterol levels in fragile X syndrome.

Authors:  Elizabeth Berry-Kravis; Rebecca Levin; Haroon Shah; Shaguna Mathur; Jennifer C Darnell; Bichun Ouyang
Journal:  Am J Med Genet A       Date:  2014-11-25       Impact factor: 2.802

4.  Dissociation of social and nonsocial anxiety in a mouse model of fragile X syndrome.

Authors:  Zhong-Hua Liu; Carolyn Beebe Smith
Journal:  Neurosci Lett       Date:  2009-03-04       Impact factor: 3.046

5.  Long-lasting effects of minocycline on behavior in young but not adult Fragile X mice.

Authors:  L E Dansie; K Phommahaxay; A G Okusanya; J Uwadia; M Huang; S E Rotschafer; K A Razak; D W Ethell; I M Ethell
Journal:  Neuroscience       Date:  2013-05-07       Impact factor: 3.590

6.  Lithium ameliorates altered glycogen synthase kinase-3 and behavior in a mouse model of fragile X syndrome.

Authors:  Christopher J Yuskaitis; Marjelo A Mines; Margaret K King; J David Sweatt; Courtney A Miller; Richard S Jope
Journal:  Biochem Pharmacol       Date:  2010-02-15       Impact factor: 5.858

7.  Macrophage migration inhibitory factor (MIF) is essential for inflammatory and neuropathic pain and enhances pain in response to stress.

Authors:  Jessica K Alexander; Gina M Cox; Jin-Bin Tian; Alicia M Zha; Ping Wei; Kristina A Kigerl; Mahesh K Reddy; Nilesh M Dagia; Theis Sielecki; Michael X Zhu; Abhay R Satoskar; Dana M McTigue; Caroline C Whitacre; Phillip G Popovich
Journal:  Exp Neurol       Date:  2012-05-01       Impact factor: 5.330

8.  GABA-B Agonist Baclofen Normalizes Auditory-Evoked Neural Oscillations and Behavioral Deficits in the Fmr1 Knockout Mouse Model of Fragile X Syndrome.

Authors:  D Sinclair; R Featherstone; M Naschek; J Nam; A Du; S Wright; K Pance; O Melnychenko; R Weger; S Akuzawa; M Matsumoto; S J Siegel
Journal:  eNeuro       Date:  2017-03-01

9.  Evaluation of the neutrophil:lymphocyte ratio as an indicator of chronic distress in the laboratory mouse.

Authors:  Debra L Hickman
Journal:  Lab Anim (NY)       Date:  2017-06-23       Impact factor: 12.625

10.  Prenatal valproic acid-induced autism marmoset model exhibits higher salivary cortisol levels.

Authors:  Madoka Nakamura; Akiko Nakagami; Keiko Nakagaki; Miyuki Yasue; Nobuyuki Kawai; Noritaka Ichinohe
Journal:  Front Behav Neurosci       Date:  2022-08-11       Impact factor: 3.617

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.